RR
Roanna Ruiz Leerink Partners Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Xeris Biopharma Holdings
XERS
$1.27B
| $7.85 | $9 |
15%
upside
| Outperform | 19 days ago |
|
2
Akebia Therapeutics
AKBA
$785M
| $2.96 | $7 |
136%
upside
| Outperform | 4 months ago |
|
3
CorMedix
CRMD
$926M
| $12.40 | $18 |
45%
upside
| Outperform | 6 months ago |
|
4
Lexicon Pharmaceuticals
LXRX
$396M
| $1.09 | $1 |
8%
downside
| Market Perform | 6 months ago |
|
5
Vir Biotechnology
VIR
$732M
| $5.27 | $20 |
280%
upside
| Outperform | 7 months ago |
|
6
ARS Pharmaceuticals
SPRY
$995M
| $10.07 | $27 |
168%
upside
| Outperform | 7 months ago |
|
7
Aquestive Therapeutics
AQST
$656M
| $5.42 | $13 |
140%
upside
| Outperform | 10 months ago |
|
8
Ardelyx
ARDX
$1.57B
| $6.52 | $14 |
115%
upside
| Outperform | 1 year ago |
|
9
United Therapeutics
UTHR
$18.1B
| $400.52 | $330 |
18%
downside
| Outperform | 1 year ago |
|
10
Cytokinetics
CYTK
$6.34B
| $53.01 | $58 |
9%
upside
| Outperform | 2 years ago |
|
11
Corcept Therapeutics
CORT
$7.31B
| $69.36 | $25 |
64%
downside
| Market Perform | 2 years ago |
|
|
12
Xeris Biopharma Holdings
XERS
$1.27B
| $7.85 | $5 |
36%
downside
| Outperform | 2 years ago |
|
|
13
Vir Biotechnology
VIR
$732M
| $5.27 | $43 |
716%
upside
| Outperform | 2 years ago |
|
14
scPharmaceuticals
SCPH
$299M
| $5.57 | $13 |
133%
upside
| Outperform | 2 years ago |
|
15
Atea Pharmaceuticals
AVIR
$267M
| $3.37 | $6 |
78%
upside
| Market Perform | 2 years ago |
|
16
NewAmsterdam Pharma
NAMS
$3.04B
| $27 | $19 |
30%
downside
| Outperform | 2 years ago |
|
|
17
ARS Pharmaceuticals
SPRY
$995M
| $10.07 | $14 |
39%
upside
| Outperform | 2 years ago |
|
18
Lantheus
LNTH
$3.72B
| $54.75 | $120 |
119%
upside
| Outperform | 2 years ago |
|
|
AMRN
19
Amarin Corp
AMRN
$317M
| $15.33 | $40 |
161%
upside
| Market Perform | 2 years ago |
|